Abstract:A novel series of peptidomimetic aldehydes was designed and synthesized to target 3C protease (3Cpro) of enterovirus 71 (EV71). Most of the compounds exhibited high antiviral activity, and among them, compound 18p demonstrated potent enzyme inhibitory activity and broad-spectrum antiviral activity on a panel of enteroviruses and rhinoviruses. The crystal structure of EV71 3Cpro in complex with 18p determined at a resolution of 1.2 Å revealed that 18p covalently linked to the catalytic Cys147 with an aldehyde group. In addition, these compounds also exhibited good inhibitory activity against the 3CLpro and the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), especially compound 18p (IC50 = 0.034 μM, EC50 = 0.29 μM). According to our previous work, these compounds have no reasons for concern regarding acute toxicity. Compared with AG7088, compound 18p also exhibited good pharmacokinetic properties and more potent anticoronavirus activity, making it an excellent lead for further development.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c02258?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c02258</a>.An overlay of EV71 3Cpro-18p and AG7088 complex structures; the binding pocket of 3Cpro of CoXB3, RV-A02, and EV71; the anti-SARS-CoV-2 activities of compounds; the 1H NMR and 13C NMR spectra of target compounds; the purity of target compounds; and the crystallography data collection and refinement statistics (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c02258/suppl_file/jm0c02258_si_001.pdf">PDF</a>)Molecular formula stings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c02258/suppl_file/jm0c02258_si_002.csv">CSV</a>)This article has not yet been cited by other publications.

Discovery and Optimization of Quinoline Analogues As Novel Potent Antivirals Against Enterovirus D68

Discovery of Potent and Broad-Spectrum Pyrazolopyridine-Containing Antivirals against Enteroviruses D68, A71, and Coxsackievirus B3 by Targeting the Viral 2C Protein

Pharmacological Characterization of the Mechanism of Action of R523062 , a Promising Antiviral for Enterovirus D68

Development of broad-spectrum enterovirus antivirals based on quinoline scaffold

Structure-Based Lead Optimization of Enterovirus D68 2A Protease Inhibitors

A Novel Peptide from VP1 of EV-D68 Exhibits Broad-Spectrum Antiviral Activity Against Human Enteroviruses

Crystallographic fragment screen of Enterovirus D68 3C protease and iterative design of lead-like compounds using structure-guided expansions

Discovery of Novel Andrographolide Derivatives as Antiviral Inhibitors against Human Enterovirus A71

New Potent EV-A71 Antivirals Targeting Capsid.

Efficacy of an isoxazole-3-carboxamide analog of pleconaril in mouse models of Enterovirus-D68 and Coxsackie B5

Design, synthesis and evaluation of 2′-acetylene-7-deaza-adenosine phosphoamidate derivatives as anti-EV71 and anti-EV-D68 agents

Design, Synthesis, and Evaluation of Novel Enterovirus 71 Inhibitors As Therapeutic Drug Leads for the Treatment of Human Hand, Foot, and Mouth Disease.

Identification, synthesis and pharmacological evaluation of novel anti-EV71 agents via cyclophilin A inhibition

Design, Synthesis, and Biological Evaluation of Peptidomimetic Aldehydes as Broad-Spectrum Inhibitors against Enterovirus and SARS-CoV-2

Discovery, Optimization and Target Identification of Novel Potent Broad-Spectrum Antiviral Inhibitors.

Novel Anti-Enterovirus A71 Compounds Discovered by Repositioning Antivirals from the Open-Source MMV Pandemic Response Box

Development of Enterovirus Antiviral Agents That Target the Viral 2C Protein

Antiviral effects and mechanisms against EV71 of the novel 2-benzoxyl-phenylpyridine derivatives

Peptidyl Aldehyde NK-1.8k Suppresses Enterovirus 71 and Enterovirus 68 Infection by Targeting Protease 3C.

Synthesis of 10,10′-bis(trifluoromethyl) marinopyrrole A derivatives and evaluation of their antiviral activities in vitro

Identification of fangchinoline as a broad-spectrum enterovirus inhibitor through reporter virus based high-content screening